Epilepsy-Associated Stigma
EPISTIGMA
EPILEPSY-ASSOCIATED STIGMA AND ILLNESS EXPERIENCE IN PEOPLE WITH EPILEPSY
1 other identifier
observational
200
1 country
1
Brief Summary
Few data about epilepsy-associated stigma in France are available. The only study we have found showed that in France 66% of people with epilepsy felt stigmatized by their condition and are often single, compared with the other European patients interviewed (Baker et al., 2000). The purpose of this study is to assess the association between type of epilepsy (drug resistant-epilepsy and stabilized epilepsy) and perceived stigma (using the Stigma Scale) in patients recruited in the Limousin region .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2011
CompletedFirst Posted
Study publicly available on registry
June 15, 2011
CompletedStudy Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedJuly 5, 2019
July 1, 2019
7.4 years
June 14, 2011
July 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
score of perceived stigma
This scale estimates a score of perceived stigma for each individual and allows classifying individuals in 3 categories. Thus, individuals who obtain a total score of 0 will be those who do not feel stigmatized. Those whose scores will be over or equal to 1will be those who feel stigmatized. Finally, respondents whose the score is equal to 3 will be considered as having a strong perception of stigma. A positive response is characterized by threshold ≥ 1.
Day one
Secondary Outcomes (2)
Evaluation of the illness experience will be performed by the first section of the EMIC.
Evaluation of the representations of epilepsy (perceived causes) will be done by the second section of the EMIC
Eligibility Criteria
This is a, descriptive and analytical study, based on a semi-directive interview among people suffering from epilepsy.
You may qualify if:
- years and above
- diagnosed by a neurologist as suffering from drug-resistant epilepsy (all types of seizures) outpatient in Neurology service of the investigation centres
- inhabitant in the Limousin region
- having signed the informed consent
- affiliated or profiting of a social security system
You may not qualify if:
- patients that are deprived of their freedom
- patients with disabilities
- patients suffering from a chronic or an acute delusional disorder
- patients suffering from others handicaps
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de neurologie
Limoges, 87042, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2011
First Posted
June 15, 2011
Study Start
July 1, 2011
Primary Completion
December 1, 2018
Study Completion
June 1, 2019
Last Updated
July 5, 2019
Record last verified: 2019-07